Alto Neuroscience Class Action Lawsuit: Investors May be Entitled to Compensation

Strategic Insights -

Purchasers of Alto Neuroscience, Inc. common stock, including those who bought shares during or after the company's initial public offering (IPO) in February 2024, may be eligible for compensation due to allegedly false and misleading statements made by the company regarding its business and clinical prospects. The lawsuit claims that investors suffered damages when the true details of Alto's ALTO-100 treatment for major depressive disorder (MDD) became public.

Key Takeaways:

  • A class action lawsuit has been filed against Alto Neuroscience, Inc. (NYSE: ANRO) on behalf of investors who purchased common stock during the IPO on February 2, 2024, and/or between February 2, 2024, and October 22, 2024.
  • The lawsuit alleges that defendants made false and misleading statements regarding Alto's business, operations, and prospects, including the effectiveness of ALTO-100 in treating MDD.
  • Investors may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.
  • The lead plaintiff deadline is September 19, 2025, for those who wish to serve as representative party in directing the litigation.
  • The Rosen Law Firm, which represents investors throughout the globe, has a track record of success in securities class actions and shareholder derivative litigation, including securing over $438 million for investors in 2019.

Statistics:

  • Alto Neuroscience, Inc. (NYSE: ANRO) was listed on the New York Stock Exchange (NYSE) in February 2024.
  • The class period for this lawsuit spans from February 2, 2024, to October 22, 2024.
  • The Rosen Law Firm has secured hundreds of millions of dollars for investors in securities class actions.
  • In 2020, company founder Laurence Rosen was named a Titan of Plaintiffs' Bar by law360.

Sources:

  • Globe Newswire, "ROSEN, A GLOBAL AND LEADING LAW FIRM, Reminds Purchasers of Alto Neuroscience, Inc. Securities of the Important Lead Plaintiff Deadline in Securities Class Action Lawsuit- ANRO" (August 4, 2025)
  • Rosen Law Firm (attorney advertising)